C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/30 (2006.01) A61K 47/48 (2006.01) A61K 51/06 (2006.01) A61K 51/10 (2006.01) C07H 21/00 (2006.01)
Patent
CA 2150477
The present invention is directed to a non-radioactive targeting immunoreagent that comprises oligonucleotides comprised of non- self-associating oligonucleotide sequences, and one or more linking groups and a radioactive targeting immunoreagent that comprises an oligonucleotide comprised of an oligonucleotide sequence that is complementary in sequence to and capable of hybridization with one or more fragments of a non-self-associating oligonucleotide sequence, one or more chelating agents, one or more linking groups and one or more radionuclides. The present invention is also directed to pharmaceutical compositions comprising one or more of the above-described immunoreagents and a pharmaceutically acceptable carrier. The present invention is further directed to methods for treating and imaging disease sites in patients.
Black Christopher Douglas Valiant
Groves Eric S.
Saha Ashis K.
Sen Arup
Shearman Clyde William
Swabey Ogilvy Renault
The Wellcome Foundation Limited
LandOfFree
Sequential targeting of tumor sites with oligonucleotide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sequential targeting of tumor sites with oligonucleotide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sequential targeting of tumor sites with oligonucleotide... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2064805